Eventide Asset Management STE Position
ActiveEventide Asset Management increased their position in STERIS plc (STE) in Q4 2025, holding $48.3M worth of shares across 190,483 shares.
The position was first reported in Q1 2023 and has been tracked across 12 quarterly 13F filings.
1 other tracked fund also holds STE.
About STERIS plc
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
Full company profile →Short Interest
2.1%
2.0 days to cover
Eventide Asset Management STE Position History
| Quarter | Action | Shares | Change | Value |
|---|---|---|---|---|
| Q4 2025 | Increased | 190,483 | +15,416 | $48.3M |
| Q3 2025 | Increased | 175,067 | +6,459 | $43.3M |
| Q2 2025 | Increased | 168,608 | +3,009 | $40.5M |
| Q1 2025 | Increased | 165,599 | +4,400 | $37.5M |
| Q4 2024 | Increased | 161,199 | +17,740 | $33.1M |
| Q3 2024 | Increased | 143,459 | +11,362 | $34.8M |
| Q2 2024 | Increased | 132,097 | +33,224 | $29.0M |
| Q1 2024 | Held | 98,873 | — | $22.2M |
| Q4 2023 | Decreased | 98,873 | -2,602 | $21.7M |
| Q3 2023 | Decreased | 101,475 | -10,171 | $22.3M |
| Q2 2023 | Decreased | 111,646 | -24,870 | $25.1M |
| Q1 2023 | New | 136,516 | +136,516 | $26.1M |
Frequently Asked Questions
Does Eventide Asset Management own STE?
Yes. As of Q4 2025, Eventide Asset Management holds 190,483 shares of STERIS plc (STE) valued at $48.3M. This data comes from their SEC 13F filing.
How many hedge funds own STE?
2 specialist biotech hedge funds currently hold STE, including Deerfield Management. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Eventide Asset Management first buy STE?
Eventide Asset Management's position in STE was first reported in Q1 2023. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Eventide Asset Management's STE position increasing or decreasing?
Eventide Asset Management increased their STE position in the most recent quarter, adding 15,416 shares.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
STECompany Page →
All fund holders, insider trades, catalysts, and cash runway
Eventide Asset ManagementPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →